Experience and Judgment

For nearly 20 years, leaders at life sciences companies and investment firms have relied on Stephen Lesser's expert advice, judgement, and insights across a range of corporate, investment, operational, and strategic matters.

After spending five years advising investment funds, banks, and companies on capital markets, investment, and M&A transactions, Stephen spent seven years at Bayer building and growing its corporate venture capital investment platform. After his time at Bayer, Stephen transitioned into private equity where he spent four years as a principal leading product finance and equity transactions and portfolio management activities for late stage pharma products and helped launch a fund focused on animal health.

Stephen currently serves on the board of directors of Vetigenics, Inc., a clinical-stage biopharmaceutical company advancing targeted antibody therapies for companion animals. In addition, Stephen has served as a speaker at the Kisaco Animal Health, Nutrition & Technology Innovation conferences in Boston and London, the Longwood Healthcare Leaders conference, and various events at the University of North Carolina at Chapel Hill Kenan-Flagler Business School.

Stephen graduated from the University of Maryland, Baltimore County, prior to earning his JD at the Washington and Lee University School of Law and his MBA at the University of North Carolina at Chapel Hill.